GNH USA

Europe — EMA

Moxtenz (Moxonidine)

GNH USA supplies Moxtenz (Moxonidine), an imidazoline receptor agonist for hypertension. Request a quote for global supply to healthcare providers worldwide.

Moxonidine

Request sourcing

1
Pack/s

What is Moxonidine?

Moxonidine, the active ingredient in Moxtenz, is an imidazoline receptor agonist presented as an oral tablet for oral use. It is used to treat hypertension in adult patients, helping to lower elevated blood pressure levels. GNH USA supplies Moxtenz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Moxonidine used for?

Moxonidine acts on the central sympathetic nervous system to manage high blood pressure. - Hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension. - Essential hypertension: improves overall blood pressure control when lifestyle measures are insufficient. - Resistant hypertension: provides an additional therapeutic option for patients whose blood pressure remains uncontrolled despite other antihypertensives.

What are the side effects of Moxonidine?

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth: sensation of reduced salivation. - Fatigue: feeling of tiredness or lack of energy. - Dizziness: light‑headedness, especially when standing quickly. - Headache: mild to moderate cranial pain. - Nausea: feeling of stomach upset. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe hypotension: markedly low blood pressure requiring medical attention. - Bradycardia: unusually slow heart rate. - Hepatic dysfunction: abnormal liver enzyme elevations. - Allergic reactions: rash, itching, or swelling. - Syncope: sudden loss of consciousness. - Electrolyte imbalance: abnormal potassium or sodium levels.

What precautions apply to Moxonidine?

Before initiating therapy with Moxonidine, certain safety considerations should be observed. - Renal impairment: adjust use in patients with reduced kidney function. - Hepatic disease: monitor liver function tests regularly. - Cardiovascular disease: use cautiously in patients with heart failure or recent myocardial infarction. - Pregnancy: avoid unless clearly needed; discuss risks with a healthcare professional. - Breastfeeding: consider potential exposure to the infant; consult a physician. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

What does Moxonidine interact with?

Moxonidine can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Clonidine: additive hypotensive effect may cause severe low blood pressure. - Beta‑blockers: combined use can lead to excessive bradycardia.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance antihypertensive response; monitor electrolytes. - ACE inhibitors or ARBs: potential for additive blood pressure reduction. - NSAIDs: may blunt antihypertensive effect; watch blood pressure trends.

Frequently asked questions

What is Moxtenz used for?+
Moxtenz contains the active ingredient Moxonidine and is prescribed to lower high blood pressure in adults. It belongs to the class of imidazoline receptor agonists and is indicated for the treatment of hypertension, including cases that are not adequately controlled by other medications.
How does Moxonidine work?+
Moxonidine selectively activates imidazoline I1 receptors in the brainstem, which reduces the activity of the sympathetic nervous system. This leads to decreased peripheral vascular resistance and lower cardiac output, ultimately resulting in a reduction of arterial blood pressure.
What is the usual dose of Moxtenz?+
The dosage of Moxtenz is individualized by a qualified prescriber based on the patient’s clinical condition, response to therapy, and any comorbidities. The prescribing physician determines the appropriate strength, frequency, and duration of treatment.
Is Moxtenz safe during pregnancy or breastfeeding?+
The safety of Moxonidine in pregnancy or while breastfeeding has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a healthcare professional.
How do I order Moxtenz from GNH USA?+
To request Moxtenz, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Moxtenz compare with other antihypertensive drugs?+
Compared with traditional centrally acting agents such as clonidine, Moxonidine has a more selective affinity for imidazoline I1 receptors, which may result in fewer sedative and dry‑mouth side effects. Its efficacy in lowering blood pressure is comparable, but the side‑effect profile can be more favorable for some patients.
What are the storage and handling requirements for Moxtenz?+
Moxtenz should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, heat, and direct sunlight, and ensure they are out of reach of children.
How is Moxtenz administered?+
Moxtenz is taken orally, usually with or without food, as directed by the prescribing clinician. Swallow the tablet whole with a glass of water; do not crush, chew, or split the tablet unless specifically instructed by a healthcare professional.
What are the most serious risks associated with Moxtenz?+
The most serious adverse events include severe hypotension, bradycardia, and rare cases of hepatic dysfunction. Patients should be monitored for symptoms such as dizziness, fainting, unusually slow heart rate, or signs of liver injury, and seek medical attention promptly if they occur.
Who should not use Moxtenz?+
Moxtenz is contraindicated in patients with known hypersensitivity to Moxonidine or any excipients in the formulation. Caution is advised, and use should be avoided, in individuals with severe renal or hepatic impairment, uncontrolled heart failure, or those taking other potent centrally acting antihypertensives without medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Moxonidine
Route
Oral Use
Manufacturer
Farmak International Sp. Z O.O.
Origin
EU

Related products

Cynt

Cynt

Moxonidine

Viatris Hrvatska D.O.O.
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Biomin, A.S.
EU